Cure Ventures

Massachusetts

Founded:2020

Firm Location:Massachusetts • Boston, Massachusetts • Cambridge, Massachusetts

Investor Firms That Co-Invest with Cure Ventures

Pfizer Venture Investments ARCH Venture Partners Third Rock Ventures The Column Group

Cure Ventures Team

Photo of Bill Amsbaugh, Partner at Cure Ventures

Cure Ventures·Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Cambridge (MA)

Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Boston / New England (Other Lists)

to see your intro paths to Bill

Photo of Milenko Cicmil, Partner at Cure Ventures

Cure Ventures·Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Boston (MA)

Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Boston / New England (Other Lists)

to see your intro paths to Milenko

Photo of David Fallace, Managing Partner at Cure Ventures

Cure Ventures·Managing Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Massachusetts

Investors in BioTech (Seed), Investors in BioTech (Series A)

to see your intro paths to David

Photo of May Han, Partner at Cure Ventures

Cure Ventures·Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Massachusetts

Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A)

to see your intro paths to May

Photo of Drew King, Partner at Cure Ventures

Cure Ventures·Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Boston (MA)

Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Boston / New England (Other Lists)

to see your intro paths to Drew

Photo of Richard Lim, Managing Partner at Cure Ventures

Cure Ventures·Managing Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Boston (MA)

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)

to see your intro paths to Richard

Photo of Kenzie Maclsaac, Partner at Cure Ventures

Kenzie Maclsaac

Cure Ventures·Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Boston (MA)

Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Boston / New England (Other Lists)

to see your intro paths to Kenzie

Photo of Lou Tartaglia, Managing Partner at Cure Ventures

Cure Ventures·Managing Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Boston (MA)

Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)

to see your intro paths to Lou

Photo of James Vath, Partner at Cure Ventures

Cure Ventures·Partner

Sweet spot: $1.5M

Range: $100K - $5.0M

Investors in Boston (MA)

Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)

to see your intro paths to James